NovaBridge Biosciences (NBP) Current Assets (2018 - 2026)

NovaBridge Biosciences (NBP) has reported Current Assets for 8 consecutive years, with $217.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Current Assets rose 23.11% year-over-year to $217.5 million; the TTM figure through Dec 2025 stood at $217.5 million (up 23.11% YoY), while the FY2025 annual figure was $217.5 million, up 23.11% from the prior year.
• Current Assets fell to $217.5 million in Q4 2025 per NBP's latest filing, from $232.8 million in the prior quarter.
• Across five years, Current Assets topped out at $747.9 billion in Q4 2021 and bottomed at $167.6 million in Q2 2025.
• Historically, Current Assets has averaged $57.8 billion across 5 years, with a median of $232.8 million in 2025.
• Annual changes were most pronounced in 2021 — Current Assets surged 92655.2% — and 2022, when it sank 99.93%.
• NovaBridge Biosciences' Current Assets stood at $747.9 billion in 2021, then tumbled by 99.93% to $509.9 million in 2022, then tumbled by 36.35% to $324.5 million in 2023, then sank by 45.55% to $176.7 million in 2024, then advanced by 23.11% to $217.5 million in 2025.
• Business Quant data shows NBP's Current Assets at $217.5 million in Q4 2025, $232.8 million in Q3 2025, and $167.6 million in Q2 2025.